Drug news
CHMP positive for Pyramax(Shin Poong Pharma) a new treatment for Malaria
The CHMP has recommended Pyramax, a fixed combination consisting of pyronaridine and artesunate, an artemisinin derivative, from Shin Poong Pharmaceutical Co, for use outside the European Union for Malaria. The CHMP opinion is intended to support registrations in countries outside the EU where there is reported artemisinin resistance. Parasitic resistance to artemisinin as well as partner drugs is on the rise.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins